Rick A. Vreman
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis.
Journal: Clinical pharmacology and therapeutics
Published: December 01, 2024
Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?
Journal: Drug discovery today
Published: October 08, 2024
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability.
Journal: PharmacoEconomics
Published: August 29, 2024
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report.
Journal: International journal of technology assessment in health care
Published: May 16, 2024
Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report.
Journal: International journal of technology assessment in health care
Published: May 10, 2024
Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis.
Journal: BMJ open
Published: February 14, 2024
Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply.
Journal: International journal of technology assessment in health care
Published: December 18, 2023
Uncertainty in Long-Term Relative Effectiveness of Medicines in Health Technology Assessment.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: December 18, 2023
Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: November 16, 2023
Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®).
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: September 27, 2023
A literature review of quality assessment and applicability to HTA of risk prediction models of coronary heart disease in patients with diabetes.
Journal: Diabetes research and clinical practice
Published: September 15, 2023
Last Updated: 09/26/2026